Prostate-specific antigen in clinical practice

This publication has 47 references indexed in Scilit:

• Reduction of Prostate Cancer Mortality in Tyrol, Austria, after Introduction of Prostate-specific Antigen Testing
  American Journal of Epidemiology, 2006
• Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
• Geographic Patterns of Prostate Cancer Mortality and Variations in Access to Medical Care in the United States
  Cancer Epidemiology, Biomarkers & Prevention, 2005
• Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter
  New England Journal of Medicine, 2004
• Natural History of Progression After PSA Elevation Following Radical Prostatectomy
  JAMA, 1999
• Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men
  Journal of Urology, 1994
• PSA-DETECTED (CLINICAL STAGE T1c OR B0) PROSTATE CANCER
  Urologic Clinics of North America, 1993
• Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer
  New England Journal of Medicine, 1991
• Prostatic Specific Antigen and Prostatic Acid Phosphatase in the Monitoring and Staging of Patients with Prostatic Cancer
  Journal of Urology, 1987
• Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate
  New England Journal of Medicine, 1987